---
figid: PMC9639040__JCMM-26-5493-g006
pmcid: PMC9639040
image_filename: JCMM-26-5493-g006.jpg
figure_link: /pmc/articles/PMC9639040/figure/jcmm17578-fig-0005/
number: FIGURE 5
figure_title: ''
caption: Enrichment of related kegg by GSEA. (A, E) Neuroactive ligand–receptor interaction
  in control (con) vs. autism (mod) and autism (mod) vs. AVP, (B, F) Calcium signalling
  pathway in control (con) vs. autism (mod) and autism (mod) vs. AVP, (C, G) N‐glycan
  biosynthesis in control (con) vs. autism (mod) and autism (mod) vs. AVP, (D, H)
  Proteasome in control (con) vs. autism (mod) and autism (mod) vs. AVP, (I, M) Ribosome
  in control (con) vs. autism (mod) and autism (mod) vs. AVP, (J, N) PPAR signalling
  pathway in control (con) vs. autism (mod) and autism (mod) vs. AVP, (K, O) Fatty
  acid metabolism in control (con) vs. autism (mod) and autism (mod) vs. AVP, (L,
  P) Toll like receptor signalling pathway in control (con) vs. autism (mod) and autism
  (mod) vs. AVP.
article_title: Effects of arginine vasopressin on the transcriptome of prefrontal
  cortex in autistic rat model.
citation: Bo Zhou, et al. J Cell Mol Med. 2022 Nov;26(21):5493-5505.
year: '2022'

doi: 10.1111/jcmm.17578
journal_title: Journal of Cellular and Molecular Medicine
journal_nlm_ta: J Cell Mol Med
publisher_name: John Wiley and Sons Inc.

keywords:
- arginine vasopressin
- autism spectrum disorder
- neurodevelopmental
- oligodendrocyte
- prefrontal cortex
- synapse

---
